Abhijeet Kumar

501 total citations
38 papers, 352 citations indexed

About

Abhijeet Kumar is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Abhijeet Kumar has authored 38 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Genetics and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Abhijeet Kumar's work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (13 papers) and CAR-T cell therapy research (8 papers). Abhijeet Kumar is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (13 papers) and CAR-T cell therapy research (8 papers). Abhijeet Kumar collaborates with scholars based in United States, Germany and Austria. Abhijeet Kumar's co-authors include Srinath Sundararajan, Dung T. Le, Joanne Jeter, Montaser Shaheen, Victor A. Levin, Philip H. Gutin, Charles B. Wilson, Edwin B. Boldrey, John F. Seymour and Jennifer A. Arzt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Abhijeet Kumar

32 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abhijeet Kumar United States 9 166 146 105 78 70 38 352
Isabelle Genvresse Germany 12 157 0.9× 99 0.7× 104 1.0× 105 1.3× 107 1.5× 27 472
Monika Długosz‐Danecka Poland 13 226 1.4× 145 1.0× 297 2.8× 58 0.7× 49 0.7× 44 485
Joseph Catlett United States 11 170 1.0× 59 0.4× 136 1.3× 129 1.7× 151 2.2× 15 501
Laetitia Coutte France 5 268 1.6× 98 0.7× 48 0.5× 53 0.7× 64 0.9× 10 386
Mujahid A. Rizvi United States 8 110 0.7× 58 0.4× 181 1.7× 42 0.5× 140 2.0× 9 464
Bertrand Filleul Belgium 8 69 0.4× 97 0.7× 65 0.6× 84 1.1× 59 0.8× 14 265
Hyewon Lee South Korea 12 150 0.9× 88 0.6× 62 0.6× 21 0.3× 127 1.8× 38 424
Anne Marie Boesen Denmark 9 178 1.1× 135 0.9× 225 2.1× 54 0.7× 54 0.8× 16 363

Countries citing papers authored by Abhijeet Kumar

Since Specialization
Citations

This map shows the geographic impact of Abhijeet Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhijeet Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhijeet Kumar more than expected).

Fields of papers citing papers by Abhijeet Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhijeet Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhijeet Kumar. The network helps show where Abhijeet Kumar may publish in the future.

Co-authorship network of co-authors of Abhijeet Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Abhijeet Kumar. A scholar is included among the top collaborators of Abhijeet Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhijeet Kumar. Abhijeet Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groisberg, Roman, Andrew Elliott, Don S. Dizon, et al.. (2025). Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma. Clinical Cancer Research. 31(11). 2210–2221.
2.
Soumerai, Jacob D., Catherine Diefenbach, Adam Asch, et al.. (2024). Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas. British Journal of Haematology. 204(5). 1762–1770. 3 indexed citations
3.
Kumar, Abhijeet, et al.. (2023). Medium‐Run Impacts of Iron‐Fortified School Lunch on Anaemia, Cognition, and Learning Outcomes in India*. Oxford Bulletin of Economics and Statistics. 85(6). 1262–1294. 2 indexed citations
4.
Kumar, Abhijeet, et al.. (2023). Smartphone-based point-of-care anemia screening in rural Bihar in India. SHILAP Revista de lepidopterología. 3(1). 38–38. 16 indexed citations
5.
6.
Kumar, Abhijeet, et al.. (2022). Anti-CD 19 CAR-T Cell Therapy with Tisagenlecleucel for Ritcher Syndrome. Blood. 140(Supplement 1). 12796–12797.
7.
Davids, Matthew S., Andrew W. Roberts, Vaishalee P. Kenkre, et al.. (2021). Long-term Follow-up of Patients with Relapsed or Refractory Non–Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study. Clinical Cancer Research. 27(17). 4690–4695. 48 indexed citations
8.
9.
Groisberg, Roman, Don S. Dizon, Andrew Elliott, et al.. (2021). Multiomic analysis to reveal distinct molecular profiles of uterine and nonuterine leiomyosarcoma.. Journal of Clinical Oncology. 39(15_suppl). 11555–11555. 2 indexed citations
10.
11.
Iftikhar, Ahmad, et al.. (2019). The efficacy of ibrutinib-based combination therapy for mantle cell lymphoma: A systematic review.. Journal of Clinical Oncology. 37(15_suppl). e19043–e19043. 1 indexed citations
12.
Kumar, Abhijeet, Muhammad Usman, Saad Ullah Malik, et al.. (2018). Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients. Current Treatment Options in Oncology. 19(10). 50–50. 10 indexed citations
13.
Puvvada, Soham D., José Guillen-Rodriguez, Abhijeet Kumar, et al.. (2017). Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas. Clinical Lymphoma Myeloma & Leukemia. 18(1). 58–64. 6 indexed citations
14.
Mahadevan, Daruka, Monica Mita, Donald Richards, et al.. (2017). Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients. Cancer Chemotherapy and Pharmacology. 79(4). 681–688. 5 indexed citations
15.
Kumar, Abhijeet, et al.. (2017). Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance. Pharmacological Research. 123. 95–102. 52 indexed citations
16.
Kumar, Abhijeet, Srinath Sundararajan, Soham D. Puvvada, & Daniel O. Persky. (2016). Limited Stage Aggressive Non-Hodgkin Lymphoma: What Is Optimal Therapy?. Current Treatment Options in Oncology. 17(9). 45–45. 1 indexed citations
17.
Sundararajan, Srinath, Abhijeet Kumar, Neha Korde, & Amit Agarwal. (2016). Smoldering Multiple Myeloma: Emerging Concepts and Therapeutics. Current Hematologic Malignancy Reports. 11(2). 102–110. 7 indexed citations
18.
Sundararajan, Srinath, et al.. (2016). Cardiovascular Adverse Effects of Targeted Antiangiogenic Drugs: Mechanisms and Management. Future Oncology. 12(8). 1067–1080. 12 indexed citations
19.
Kumar, Abhijeet, Meenakshi Dagar, Joseph M. Herman, Christine A. Iacobuzio–Donahue, & Dan Laheru. (2014). CNS Involvement in Pancreatic Adenocarcinoma: a Report of Eight Cases from the Johns Hopkins Hospital and Review of Literature. Journal of Gastrointestinal Cancer. 46(1). 5–8. 19 indexed citations
20.
Kumar, Abhijeet & Dung T. Le. (2014). Hepatocellular Carcinoma Regression After Cessation of Immunosuppressive Therapy. Journal of Clinical Oncology. 34(10). e90–e92. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Genvresse Breakdown of academic impact, for papers by Monika Długosz‐Danecka Breakdown of academic impact, for papers by Joseph Catlett Breakdown of academic impact, for papers by Laetitia Coutte Breakdown of academic impact, for papers by Mujahid A. Rizvi Breakdown of academic impact, for papers by Bertrand Filleul Breakdown of academic impact, for papers by Hyewon Lee Breakdown of academic impact, for papers by Anne Marie Boesen
Rankless by CCL
2026